查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1858816

單細胞分析市場機會、成長促進因素、產業趨勢分析及預測（2025-2034年）

Single-cell Analysis Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
出版日期: | 出版商: Global Market Insights Inc. | 英文 140 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024 年全球單細胞分析市場價值為 43 億美元，預計到 2034 年將以 16.7% 的複合年成長率成長至 200 億美元。

單細胞分析市場 - IMG1

強勁的成長動力源自於人們對個人化醫療日益成長的興趣，以及轉錄組學和基因組學技術的不斷進步。單細胞分析使科學家能夠研究複雜細胞群中單一細胞的獨特行為，從而更深入地了解疾病進展、抗藥性、免疫反應和轉移。該技術在檢測罕見癌細胞、評估治療反應和揭示細胞異質性方面發揮著至關重要的作用。與傳統的批量分析不同，單細胞技術能夠提供高解析度資料，這對於研究腫瘤演變、罕見遺傳疾病和細胞發育至關重要。由於樣本量小且靈敏度高，這些方法依賴高度精確的操作流程。在單細胞層面整合轉錄組學、表觀基因組學、蛋白質組學和代謝組學等多組學數據，有助於全面了解細胞功能。此外，3D空間組學技術的進步使研究人員能夠在細胞的天然組織環境中探索細胞相互作用和環境訊號，從而更深入地了解生物系統，並推動其在診斷、藥物研發和再生醫學等領域的應用。

市場範圍
起始年份 2024
預測年份 2025-2034
起始值 43億美元
預測值 200億美元
複合年成長率 16.7%

2024年，耗材市場佔據56.3%的市場佔有率，預計到2034年將達到114億美元，年複合成長率達16.9%。該市場涵蓋試劑、磁珠、檢測試劑盒和微流控晶片等單細胞工作流程的關鍵產品。由於這些產品在每次實驗中都會消耗，且需要定期補充，因此需求持續強勁。幹細胞生物學、免疫療法和腫瘤學等領域的研究日益增多，尤其是在學術和商業環境中研究人員擴大實驗規模的情況下，進一步推動了耗材的需求。

基因組學（DNA）應用領域預計在2024年創造18億美元的市場規模。單細胞基因組學提供了一種強大的方法來檢測單一細胞之間的遺傳差異，從而深入了解染色體變異、突變和克隆演化。這項技術對於在精細層面研究疾病機制、識別殘留病灶以及發現可能在批量DNA分析中被忽略的罕見遺傳變異至關重要。它在追蹤腫瘤亞群和了解複雜組織的遺傳組成方面尤其有價值。

2024年，北美單細胞分析市佔率達45.1%。該地區的領先地位源於其在研發領域的強勁投入，尤其是在美國，眾多大型生物技術和製藥公司的存在為持續創新提供了有力支撐。高額的醫療保健支出使醫療機構能夠採用尖端技術，而學術研究中心和臨床試驗網路則積極支持單細胞技術在廣泛治療領域的應用。

全球單細胞分析市場的主要參與者包括Illumina、Takara Bio、10X Genomics、Sartorius、Oxford Nanopore Technologies、Thermo Fisher Scientific、Merck KGaA、Agilent Technologies、華大基因、Fluidigm Corporation（Standard Bio Tools）、NanoString Technologies、諾禾源、Bio-Vaborator, Laborator, Gaborator. (NVKelator, Gaborator, Gaborator, Gaborator）。為了鞏固其在單細胞分析市場的地位，領先企業正在拓展產品線，將基因組學、蛋白質組學和太空技術整合到多組學平台中。許多企業正與學術機構和生物製藥公司建立合作關係，以支持大規模研究計畫。研發投入仍是企業的核心重點，微流控、定序技術和自動化工具領域持續創新。此外，各公司也正在透過加強分銷網路和建立新設施來擴大其全球影響力，以滿足不斷成長的市場需求。

目錄

第1章：方法論與範圍

第2章：執行概要

第3章：行業洞察

  • 產業生態系分析
  • 產業影響因素
    • 成長促進因素
      • 對個人化醫療的需求日益成長
      • 基因組學和轉錄組學技術的進步
      • 癌症研究領域中日益成長的應用
      • 增加政府和私人資金投入
    • 產業陷阱與挑戰
      • 儀器和試劑成本高昂
      • 複雜資料分析與解讀
    • 市場機遇
      • 臨床診斷領域的不斷擴張
      • 生物技術和製藥合作的成長
  • 成長潛力分析
  • 監管環境
    • 北美洲
      • 美國
      • 加拿大
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 技術格局
    • 當前技術趨勢
    • 新興技術
  • 管道分析
  • 定價分析
  • 未來市場趨勢
  • 波特的分析
  • PESTEL 分析

第4章：競爭格局

  • 介紹
  • 公司市佔率分析
    • 全球的
    • 北美洲
    • 歐洲
  • 公司矩陣分析
  • 主要市場參與者的競爭分析
  • 競爭定位矩陣
  • 關鍵進展
    • 併購
    • 夥伴關係與合作
    • 新產品發布
    • 擴張計劃

第5章：市場估算與預測：依產品分類，2021-2034年

  • 主要趨勢
  • 消耗品
    • 試劑
    • 檢測試劑盒
  • 儀器
    • 顯微鏡
    • 血球計數器
    • 流式細胞儀
    • 下一代定序
    • 高內涵篩選系統
    • 其他樂器

第6章：市場估算與預測：依分析類型分類，2021-2034年

  • 主要趨勢
  • 基因組學（DNA）
  • 轉錄組學
  • 表觀基因組學
  • 多組學整合
  • 其他分析類型

第7章：市場估計與預測：依應用領域分類，2021-2034年

  • 主要趨勢
  • 臨床診斷
  • 研究
  • 藥物發現與開發
  • 其他應用

第8章：市場估算與預測：依最終用途分類，2021-2034年

  • 主要趨勢
  • 學術和研究實驗室
  • 生物技術和製藥公司
  • 醫院和診斷實驗室
  • 其他最終用途

第9章：市場估計與預測：依地區分類，2021-2034年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第10章：公司簡介

  • 10X Genomics
  • Agilent Technologies
  • Becton, Dickinson & Company (BD)
  • Bio-Rad Laboratories
  • BGI Genomics
  • Fluidigm Corporation (Standard Bio Tools)
  • Illumina
  • Merck KGaA
  • NanoString Technologies
  • Novogene
  • Oxford Nanopore Technologies
  • QIAGEN NV
  • Sartorius
  • Takara Bio
  • Thermo Fisher Scientific
簡介目錄
Product Code: 14911

The Global Single-cell Analysis Market was valued at USD 4.3 billion in 2024 and is estimated to grow at a CAGR of 16.7% to reach USD 20 billion by 2034.

Single-cell Analysis Market - IMG1

The strong growth is driven by increasing interest in personalized medicine and continued advances in transcriptomics and genomics technologies. Single-cell analysis allows scientists to examine the unique behavior of individual cells within complex populations, offering a deeper understanding of disease progression, drug resistance, immune responses, and metastasis. The technology plays a vital role in detecting rare cancer cells, assessing treatment responses, and uncovering cellular heterogeneity. Unlike conventional bulk analysis, single-cell techniques deliver high-resolution data that is crucial for studying tumor evolution, rare genetic disorders, and cellular development. Due to the low volume and sensitivity of samples, these methods rely on highly precise protocols. The integration of multi-omics covering transcriptomics, epigenomics, proteomics, and metabolomics at the single-cell level helps deliver a comprehensive picture of cell function. Additionally, advancements in 3D spatial omics technologies allow researchers to explore cellular interactions and environmental cues in their native tissue context, unlocking deeper insights into biological systems and advancing applications in diagnostics, drug discovery, and regenerative medicine.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$4.3 Billion
Forecast Value$20 Billion
CAGR16.7%

The consumables segment held a 56.3% share in 2024 and is forecasted to reach USD 11.4 billion by 2034, growing at a CAGR of 16.9%. This segment includes reagents, beads, assay kits, and microfluidic cartridges that are critical for single-cell workflows. As these products are consumed in every experiment and must be replenished regularly, they create ongoing demand. The increasing frequency of studies in fields like stem cell biology, immunotherapy, and oncology is fueling the need for consumables, especially as researchers scale up experiments in academic and commercial settings.

The genomics (DNA) application segment generated USD 1.8 billion in 2024. Single-cell genomics provides a powerful way to detect genetic differences between individual cells, offering insight into chromosomal variations, mutations, and clonal evolution. This technology is instrumental in studying disease mechanisms at a granular level, identifying residual disease, and uncovering rare genetic variants that may be overlooked in bulk DNA analysis. It is especially valuable in tracking tumor subpopulations and understanding the genetic makeup of complex tissues.

North America Single-cell Analysis Market held a 45.1% share in 2024. The region's leadership stems from strong investments in R&D, particularly in the U.S., where the presence of major biotech and pharmaceutical companies supports continued innovation. High healthcare spending enables institutions to adopt sophisticated technologies, while academic research hubs and clinical trial networks actively support the growth of single-cell technologies across a wide range of therapeutic areas.

Key players in the Global Single-cell Analysis Market include Illumina, Takara Bio, 10X Genomics, Sartorius, Oxford Nanopore Technologies, Thermo Fisher Scientific, Merck KGaA, Agilent Technologies, BGI Genomics, Fluidigm Corporation (Standard Bio Tools), NanoString Technologies, Novogene, Bio-Rad Laboratories, QIAGEN NV, and Becton, Dickinson & Company (BD). To solidify their position in the Single-cell Analysis Market, leading companies are expanding their product lines to include multi-omics platforms that integrate genomic, proteomic, and spatial technologies. Many are forging partnerships with academic institutions and biopharma firms to support large-scale research projects. Investment in R&D remains a core focus, with continuous innovation in microfluidics, sequencing technologies, and automation tools. Firms are also increasing their global footprint by enhancing distribution networks and establishing new facilities to meet growing demand.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definition
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Data mining sources
    • 1.3.1 Global
    • 1.3.2 Regional/Country
  • 1.4 Base estimates and calculations
    • 1.4.1 Base year calculation
    • 1.4.2 Key trends for market estimation
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
  • 1.6 Forecast model
  • 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis
  • 2.2 Key market trends
    • 2.2.1 Regional trends
    • 2.2.2 Component trends
    • 2.2.3 Application trends
    • 2.2.4 End use trends
  • 2.3 CXO perspectives: Strategic imperatives
    • 2.3.1 Key decision points for industry executives
    • 2.3.2 Critical success factors for market players
  • 2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Growing demand for personalized medicine
      • 3.2.1.2 Advancement in genomics and transcriptomics technologies
      • 3.2.1.3 Growing applications in cancer research
      • 3.2.1.4 Increasing government and private funding
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High cost of instruments and reagents
      • 3.2.2.2 Complex data analysis and interpretation
    • 3.2.3 Market opportunities
      • 3.2.3.1 Increasing expansion in clinical diagnostics
      • 3.2.3.2 Growth in biotech and pharma collaborations
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
    • 3.4.1 North America
      • 3.4.1.1 U.S.
      • 3.4.1.2 Canada
    • 3.4.2 Europe
    • 3.4.3 Asia Pacific
    • 3.4.4 Latin America
    • 3.4.5 Middle East and Africa
  • 3.5 Technology landscape
    • 3.5.1 Current technological trends
    • 3.5.2 Emerging technologies
  • 3.6 Pipeline analysis
  • 3.7 Pricing analysis
  • 3.8 Future market trends
  • 3.9 Porter's analysis
  • 3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company market share analysis
    • 4.2.1 Global
    • 4.2.2 North America
    • 4.2.3 Europe
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Key developments
    • 4.6.1 Merger and acquisition
    • 4.6.2 Partnership and collaboration
    • 4.6.3 New product launches
    • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2034 ($ Mn)

  • 5.1 Key trends
  • 5.2 Consumables
    • 5.2.1 Reagents
    • 5.2.2 Assay Kits
  • 5.3 Instruments
    • 5.3.1 Microscopes
    • 5.3.2 Hemocytometers
    • 5.3.3 Flow cytometers
    • 5.3.4 Next generation sequencing
    • 5.3.5 High-content screening system
    • 5.3.6 Other instruments

Chapter 6 Market Estimates and Forecast, By Analysis Type, 2021 - 2034 ($ Mn)

  • 6.1 Key trends
  • 6.2 Genomics (DNA)
  • 6.3 Transcriptomics
  • 6.4 Epigenomics
  • 6.5 Multiomics integration
  • 6.6 Other analysis types

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)

  • 7.1 Key trends
  • 7.2 Clinical diagnostics
  • 7.3 Research
  • 7.4 Drug discovery & development
  • 7.5 Other applications

Chapter 8 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

  • 8.1 Key trends
  • 8.2 Academic and research laboratories
  • 8.3 Biotechnology and pharmaceutical companies
  • 8.4 Hospitals and diagnostic laboratories
  • 8.5 Other end use

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Netherlands
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 India
    • 9.4.3 Japan
    • 9.4.4 Australia
    • 9.4.5 South Korea
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE

Chapter 10 Company Profiles

  • 10.1 10X Genomics
  • 10.2 Agilent Technologies
  • 10.3 Becton, Dickinson & Company (BD)
  • 10.4 Bio-Rad Laboratories
  • 10.5 BGI Genomics
  • 10.6 Fluidigm Corporation (Standard Bio Tools)
  • 10.7 Illumina
  • 10.8 Merck KGaA
  • 10.9 NanoString Technologies
  • 10.10 Novogene
  • 10.11 Oxford Nanopore Technologies
  • 10.12 QIAGEN NV
  • 10.13 Sartorius
  • 10.14 Takara Bio
  • 10.15 Thermo Fisher Scientific